VOLUME 29 NUMBER 9 SEPTEMBER 2011 nature biotechnology r e s o u r c e miRNAs regulate protein expression through sequence-specific base pairing with target mRNAs reducing both their stability and the process of protein translation 1,2 . At least 30% of protein-coding genes appear to be conserved targets for miRNAs 1 . The influence and importance of miRNAs as regulators of gene expression has led to their intensive study in many biological disciplines, ranging from cell cycle regulation 3 , stem cell development and differentiation 4 to cardiac function 5, 6 , neurobiology 7 and immunology 8 . The dysregulation of miRNA expression is frequently associated with cancer development 9 and the role of miRNAs in cellular proliferation and differentiation has raised opportunities for new strategies for therapeutic intervention in the disease process. A genome-wide miRNA knockout resource for the functional analysis of miRNAs currently exists only for the invertebrate Caenorhabditis elegans 10 in contrast to coding gene knockout resources that are now well advanced in the mouse 11, 12, 13 . Much of our knowledge of miRNA function in mice comes from overexpression studies or the disruption of all miRNAs by tissue-restricted knockout of the processing enzyme Dicer [14] [15] [16] . A limited number of individual miRNA knockout mice have been described, which have provided information on areas such as B-cell 17,18 and regulatory T-cell 19 function and cardiac development and function 5, 6 . The analysis of miRNA knockout alleles is complicated by the presence of several miRNA genes with related predicted specificities at multiple loci 20 , which suggests functional redundancy at the level of target specificity, although this is probably modulated by specific temporal and spatial expression patterns. Rigorous analysis of miRNA function will require the creation of compound mutants of miRNA family members for which a resource of knockout ES cells will be valuable.
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We have designed the miRNA knockout (mirKO) resource as a research toolbox of mutant alleles that can be used as reagents for studying miRNA function in a range of complementary approaches. We demonstrate how recombinase-mediated cassette exchange (RMCE) can be used to efficiently modify each mutated miRNA locus, replacing the targeted allele with any desired sequence to generate reporter and conditional alleles or a host of other possible allelic variants.
RESULTS

Production of mirKO targeting vectors
The gene structures for most mammalian miRNAs are not well defined, and the promoter regions have been established only in a few cases 21, 22 . However, miRNAs are generally transcribed from PolII promoters and the primary transcripts are 5′ 7-methyl guanylate capped and 3′-polyadenylated 21, 23 . miRNA genes can be within the introns of coding or noncoding genes, within the exons of noncoding genes, or intergenic 24 . As many miRNAs are encoded within the expanse of other loci, knockout alleles were designed to disrupt the activity of the miRNA without disturbing the function of the gene in which they are embedded. However, in a small number of cases, exons of coding or noncoding genes were disrupted by the targeting vectors.
For individual (singleton) miRNA genes, targeting vectors were designed to generate small deletions (typically 100-300 bp). In cases where miRNA genes are close to one another (<300 bp apart), the vectors were designed to delete clusters to minimize the adventitious disruption of their neighbor(s). We adapted this general principle when we considered that there was particular value in generating larger deletions, for instance, clustered miRNA gene family members.
Targeting vectors were designed with slightly asymmetric homology arms of 3 kb and 5 kb to support robust long-range PCR genotyping for correct targeting. The targeting vectors incorporate site-specific recombinase sites flanking the selection cassette to facilitate removal of the cassette leaving just a small deletion and/or enabling further modification of the locus. We have attempted to make targeting vectors for all of the genes in the miRBase registry (release 14) 20 of miRNAs except for those on chromosome 2 between NCBIm37 coordinates r e s o u r c e 10,386,914 and 10,439,906 bp, as this region contains several families of repetitive miRNA genes of low sequence complexity. Excluding this region, the 513 other miRNA genes in miRBase (release 14) corresponded to 455 individual targeting vector designs. Of these, we did not attempt to design vectors for 9 and a further 8 failed at the automated vector design stage, leaving 438 possible vector designs that correspond to 494 (97%) of the miRNA genes on our target list.
Targeting vectors were constructed using three cycles of recombineering in Escherichia coli ( Fig. 1; Supplementary Fig. 1a ,b for novel plasmid reagents) 25 . This process yielded vectors for 428 (98%) of the 438 available designs, covering 476 miRNA genes (Supplementary Table 1 ). For each design, two targeting vectors were produced with either a neomycin or a puromycin-delta thymidine kinase fusion gene (puro∆tk) 26 for positive or positive-negative selection in ES cells, respectively. The availability of targeting vectors with two different selection markers supports the generation of homozygous mutant ES cells for each miRNA by serial targeting in ES cells. Both versions possessed selection cassettes flanked by loxP sites and also the FLP recombinase recognition sites FRT and the mutant F3 in reverse orientation 27 .
Production of mirKO targeted ES cells ES cells from the C57BL/6N mouse strain were used for generating the resource, enabling the mutant alleles to be produced in a defined genetic background and thus avoiding the complication of assessing mouse phenotypes in an outbred population 28 . Gene targeting was initially piloted in the wild-type JM8.F6 ES cell clone. The isogenic derivative JM8.A3 (ref. 28 ) was used subsequently to generate the bulk of the resource. The JM8.A3 cell line enables chimeric mice to be scored by the presence of agouti coat color using host embryos from the C57BL6 strain, whereas germline transmission can be scored in crosses with C57BL/6N females by the presence of the agouti coat color in their offspring.
The miRNA targeting vectors with the puro∆tk cassette were used to generate the resource. Representative examples for the gene targeting of the mir-290~295 cluster, mir-21 and mir-106a~363 cluster are depicted in Figures 2-4 , respectively. In general, sets of 32 puromycinresistant clones were screened by long-range PCR across the short arm of the vector to identify targeted clones. Overall, 70% of targeting vectors yielded at least one targeted clone from the first set of 32 clones analyzed with an overall average targeting frequency of 25%. The targeting frequencies ranged from 92% to <1% (Supplementary Fig. 2) . In cases where targeting failed, or generated fewer than three positive clones, we performed additional rounds of targeting and screened successive sets of clones, which increased the overall vector success rate to 81%. Overall, we have successfully generated targeted deletions for 392 (79%) of the intended 494 miRNA genes, either as singletons or as clusters, after excluding candidate miRNAs that were removed from later versions of miRBase (Supplementary Table 1 ).
Up to six independent, targeted ES cell clones for each allele were reassessed by long-range PCR across both homology arms and archived in replicate copies. The presence of products migrating at the expected size on standard 0.8% agarose gels for both PCR reactions was taken as high confidence that the targeting was successful and that the correct clones had been expanded (Figs. 2b,3b and 4b) . In a few cases PCR genotyping of the long homology arm was not successful for all clones corresponding to one allele. Analysis of three sets of failures by Southern blot analysis revealed that in most cases these were correctly targeted false negatives resulting from failure in long-range PCR (data not shown).
The sets of recombinase recognition sites flanking the selection cassette in the targeted loci supports directed manipulation of each allele. The puro∆tk positive-negative selection cassette makes these events selectable in gancyclovir or 2-Fluoro-2-deoxy-1-d-arabinofuranosyl-5-iodouracil (FIAU) 26 . The puro∆tk selection cassette flanked by loxP sites in direct orientation can be efficiently removed by expression of Cre followed by FIAU selection (Figs. 2,3 and Supplementary Fig. 3 ), leaving a marker-free locus with a small deletion.
The utility of the resource for the establishing alleles in mice was assessed by injection of targeted clones into C57BL/6J-Tyr c-Brd blastocysts and test breeding of the resultant chimeric mice ( Table 1) . Half of targeted clones generated from the JM8.F6 parental line gave germline transmission of the targeted allele (n = 4). For the JM8.A3 ES cell clones used for the majority of the resource, 71% of injected clones (n = 24) or 91% of those clones that gave male chimeras (n = 19) yielded germline transmission. mirKO alleles are efficient substrates for RMCE The FRT and F3 sites flanking the puro∆tk cassette facilitate RMCE 27 . Co-transfection of a codon-optimized FLPo recombinase 29 expression vector with a suitable exchange plasmid carrying a PGK-neo-bpA expression cassette catalyzed 100% efficient cassette exchange in G418 plus FIAU-selected ES cell clones at all loci tested ( Table 2, Supplementary  Table 2 and Supplementary Fig. 4 ). Selection in G418 alone also yielded successful cassette exchange events, but at a lower frequency (Supplementary Table 2 ). The efficiency of RMCE allows the puro∆tk alleles in the heterozygous ES cell resource to be rapidly converted into alternative allelic variants (Figs. 2-4 and Supplementary Fig. 4 ).
Reporter alleles generated by RMCE We demonstrate the ability to manipulate mirKO mutants by the introduction of the fluorescent reporter gene Td-tomato at two and Supplementary Fig. 1c ). To facilitate authentic expression from the endogenous miRNA promoter, we removed the PGK-neo-bpA selection cassette by transiently transfecting cells with a plasmid expressing Dre recombinase, which induced recombination between the flanking Rox sites 30, 31 . The miR-290~295 cluster miRNAs are highly represented in ES cells 32, 33 , being expressed intergenically from a defined promoter 22 and function in the maintenance of ES cell proliferation and pluripotency 7, 8 . Td-tomato at the mir-290~295 cluster showed high expression in undifferentiated ES cells that subsided upon differentiation, a result consistent with the reported expression pattern of the cluster (Fig. 2) . mir-21 is located within the 3′ UTR of Tmem49, but is expressed from a promoter located between Tmem49 exons 11 and 12 (ref. 21) . Td-tomato expression at the mir-21 locus was not detectable in living undifferentiated ES cells or embryoid bodies formed during the first few days of the differentiation process. However, for later-stage differentiating embryoid bodies (~10 d and later), red fluorescence appeared in some cells expressing Td-tomato (Fig. 3) . There was no fluorescence within control mir-21 Puro∆tk/+ cells not expressing Td-tomato. This is consistent with the previously reported low representation of miR-21 in undifferentiated ES cells 22, 33 and the greatly increased presence upon differentiation in utero 33 .
Conditional alleles generated by RMCE
To demonstrate the conversion of the puro∆tk allele to a conditional allele, we have chosen the X-linked mir-106a~363 cluster (Fig. 4) . The genomic sequence of the cluster was reintroduced by RMCE in place of the puro∆tk alleles such that it is flanked by loxP sites. The conditional allele was finalized by Dre deletion of the PGK neo cassette. The status of the mir-106a~363 cluster at each step of the conversion process was assessed by PCR with flanking primers. The expression levels relative to parental JM8.A3 ES cells for each mature miRNA within the cluster for the allelic variant ES cell clones were determined by comparative quantitative PCR. The expression of miR-18b, miR-20b and miR-363 were all much lower or undetectable in the null ES cell clones, but were expressed in the conditional ES cell clone. There was high expression of miR-19b and miR-92a in mir-106a~363 cluster null ES cell clones (data not shown), but this is explained by the presence as homologs of these miRNAs expressed from the miR-17~92a-1 cluster on chromosome 14, which are also detected by the TaqMan assays used. The reason for the detection of high levels of miR-106a is unresolved as the TaqMan assay was described as being specific for this miRNA.
Accessing and using the mirKO resource To inform researchers of the availability and technical details of the mirKO reagents, we have entered this information onto the International r e s o u r c e Knockout Mouse Consortium (IKMC) web portal (http://www.knock outmouse.org/martsearch), which is editable and will be modified as the resource develops 13 . Contingent upon successful expansion and genotyping quality control by long-range PCR, targeted ES cell clones are being transferred to repositories for distribution. Within the IKMC web portal, links are provided to order clones form either of the two participating repositories MMRRC (http://www.mmrrc.org/) at the University of California Davis, USA, and EuMMCR at the Helmholtz Zentrum München (http://www.eummcr.org/), Munich. The IKMC web portal has been described in detail elsewhere 13 , so the following is only a brief description relating to the mirKO reagents. The mirKO reagents on the IKMC web portal can be searched using the MGI (Mouse Genome Informatics) number, Ensembl gene identifier or the miRBase registry designation. A link through a mirKO project number provides a summary diagram of individual targeting vectors. Each vector has a unique design ID that links through to the highthroughput gene targeting design for the particular miRNA knockout that provides information on the oligonucleotide homology arms used for recombineering with associated genomic coordinates (NCBIM37 assembly). Each targeting vector has been given a name with a prefix (mirKO_TV_PuDtk) followed by a unique address within the stock glycerol plates. Each targeting vector has a linked annotated sequence file deposited within the IKMC database. The targeting vectors will be available to order from repositories so as to enable the initiation of new targeting experiments.
For each miRNA knockout project, all available targeted ES cell clones are listed in the form mirKO_ES_PuDtk_ID, where the ID number describes the matrix plate number and address where the clone is stored. The parental ES cell line (JM8.F6 or JM8.A3) is listed against each ES cell clone. There is a linked annotated sequence file comprising the selection cassette that replaced the miRNA and genomic flanking sequence. The binding sites of the long-range PCR primers used for genotype verification at both ends of the targeting event are indicated as LR1, LR2, LR3 and LR4. Within the quality control data, the status of the long-range genotyping PCR is summarized. r e s o u r c e After targeted ES cell clones have been received from a repository, we recommend that they be expanded on feeder cells under antibiotic selection and frozen into multiple vials for future use in addition to making genomic DNA 28 . It is important that the targeting status is independently verified by the recipient before use. As a minimum, this should be by successful repetition of the long-range PCR at both ends of the targeting event. In cases where the production and distribution centers have not been successful in performing the PCR at the long arm, we strongly recommend that the recipient use Southern blot analysis to verify correct targeting. Although we do not believe it is essential where long-range PCR results are clear, and indeed it was impractical for us to develop at large-scale during knockout production, a Southern blot analysis strategy will be a useful genotyping protocol to have available for all mirKO projects. After genotype verification where a simple miRNA deletion is required and the puro∆tk selection cassette is removed by Cre recombinase transfection in tissue culture, then an additional short-range PCR should be developed by the recipient. This is most easily performed by PCR across the deletion although alternative approaches may be required where the mutant and wild-type PCR products are very similar in size (indistinguishable) or very different in size (the longer PCR product may be inefficiently amplified) (Supplementary Fig. 3 ).
DISCUSSION
We established a mouse miRNA knockout resource in ES cells for the majority of the miRNAs currently in the miRBase registry. These miRNA alleles were generated in C57BL/6N ES cells, which has been adopted as the standard genetic background for knockouts. Most of the targeted alleles were made using the JM8.A3 ES cell clone which enables visual identification of chimerism and germline transmission by agouti coat color in the widely used C57BL/6 strain. In practical terms, this allows an inbred genetic background to be maintained while still using coat color markers, reducing the number of mice used and genotyping 28 . The germline transmission efficiency of the clones from the resource are similar to those reported previously 28 . r e s o u r c e as simple deletions of the miRNA but the design enables efficient post-targeting modification to be accomplished by RMCE, allowing a multitude of alternative alleles to be efficiently produced. We have demonstrated the conversion of puro∆tk-targeted alleles to reporter and conditional alleles. Other examples of possible applications might include the variation of miRNA copy number and mutating individual miRNAs within clusters. Clones are available in public repositories and details of the targeted ES cell clones and alleles have been entered onto a publically viewable database of the International Mouse Knockout Consortium (http://www.knockoutmouse.org/martsearch) 13 .
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturebiotechnology/.
Note: Supplementary information is available on the Nature Biotechnology website.
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AUtHoR ContRIBUtIons
E. coli. Clones that grew on puromycin but failed to grow on kanamycin plates were considered as candidates for puromycin-selective targeting vectors. They were picked and arrayed in 96-deep-well plates with 2 × tryptone yeast extract medium (2×TY) containing 50 µg/ml ampicillin, and were inoculated into four replicates for overnight culture. The overnight cultures of puromycinresistant clones were pooled and the pelleted 4 ml of bacterial growth was miniprepped using 96-well TurboPrep columns (Qiagen). The DNA preps were restriction digested and submitted for sequence verification as previously described. Individual targeting vector clones that had passed quality control were picked into 850 µl of puromycin TB with 50 µg/ml carbenocillin to create a 'puromycin Master-Plate' from which a glycerol stock was made. The Puro-TV were maxiprepped from 500 ml of 2×TY with 50 µg/ml ampicillin using the Qiagen kit to provide a stock of DNA for ES cell targeting.
ES cell culture. JM8.F6 and JM8.A3 cells are C57Black/6N-derived, feederdependent ES cell clones that were grown on neomycin-and puromycinresistant SNL7 fibroblasts 36 in DMEM media containing 15% FCS as previously described 28 . The Puro-TV were linearized by FseI or AscI digest. Linearized DNA was ethanol precipitated, washed with 70% ethanol, air dried and 20 µg was electroporated into 1 × 10 7 ES cells (Biorad) 230 V, 500 µF. Selection with puromycin (3 µg ml -1 ) was begun after 24 h and continued for a further 8 d with daily media changes. As a routine, 32 colonies were picked for each transfection, although this was often increased to 48 or 96 colonies for where initial transfections yielded very few or no positive clones so that repeated transfection was required. The ES cell clones were expanded and frozen in 96-well formats in 10% DMSO and 50% FCS and genomic DNA was extracted from a replicate. After primary screen PCR amplification, positive clones were thawed into a single well of a 24-well plate and then expanded up to the equivalent of a single well of a 6-well plate. Finally each ES cell clone was frozen into Matrix vials (Thermo). In general up to six independent clones of each targeted miRNA gene were archived. ES cells were differentiated using the embryoid body method as previously described 37 . Approximately 600 ES cells were suspended in 20 µl hanging drops in differentiation medium. After 2 d the aggregated cells were washed into bacterial dishes with differentiation medium and cultured for a further 4 d. The embryoid bodies were then seeded onto gelatinized tissue culture plates.
PCR genotyping of ES cell clones. ES cell clones were routinely genotyped by long-range PCR. PCR primers were selected using the Primer 3 software (http://frodo.wi.mit.edu/primer3/). Standard primers were selected at the 5′ end (LR2: 5′-tctagaaagtataggaacttccatggtc-3′) and 3′ end (LR3: 5-attataatt gagatctggtaagttatttgc-3′) end of the selection cassette. Primers (LR1 and LR4) were chosen that lay external to the homology arms so that appearance of the expected length of PCR product was indicative of a correctly targeted ES cell clone. Either the Sequal Prep (Invitrogen) or Longamp (New England Biolabs) kits were used for the long-range PCR. During the primary genotyping screen from 96-well plates only the product for the short arm was amplified. During the secondary screen after amplification of the ES cell clones the short-arm PCR was repeated to confirm that the correct ES cell had been expanded, but in addition the clone was analyzed for the correct long-arm PCR product. Vector design. The miRNA targets were selected using the miRBase registry (http://www.mirbase.org/) 20, 34 . Manually annotated files of predicted sequences for all of the targeting vectors and targeted alleles were generated using the Vector NTI software (Invitrogen). The 50-bp homology arms for vector construction were selected using the WTSI high-throughput gene targeting (htgt) software (http://www.sanger.ac.uk/htgt/welcome). Oligonucleotides homologous sequences with appended PCR primer sequences were ordered from Sigma-Genosys. As standard the vectors were designed to have homology arms of 5.5 kb (± 500 bp) and 3.3 kb (± 300 bp), and with deletions as small as possible surrounding the region corresponding to the stem-loop sequence of the pre-miRNA (http://www.sanger.ac.uk/htgt/welcome).
Recombineering fragment preparation. The neomycin/kanamycin selection cassette pHPmK3 (GenBank accession JN195814) was derived from the plasmid pL452 (ref. 35) . The flanking recombinase recognition sites were modified to include an FRT and F3 inverted relative to each by cloning of annealed complementary oligonucleotides. PL611 was used as vector backbone for retrieval of the targeting vector from the BAC clone 25 . The puromycin/thymidine kinase selection cassette pHPmF1 (GenBank accession JN195815) was made by cloning the bacterial EM7 promoter within a 465-bp AgeI/NcoI PL452 fragment and subcloned at the same restriction sites 5′ to the puromycin resistance gene in YTC37 (ref. 26) .
In preparation for recombineering (i) pHP-mK3 was digested with NotI and SalI to release a FRT-loxP-PGK-EM7-Neo-bpA-F3-LoxP fragment, (ii) pL611 was digested with BamHI and EcoRI and (iii) pHP-mF1 was digested with HindIII and XhoI to release a PGK-EM7-Puro∆tk-bpA fragment. The digests were electrophoresed and the appropriate fragments were excised from the agarose gel and then underwent one or two more rounds of digestion and gel excision. The final eluted products were test transformed into electrocompetent DH10B (Invitrogen), spread on appropriate selective agar plates, to test for plasmid contamination. The pHP-mK3 and pPL611 isolated fragments were used as templates for PCR of recombineering fragments using the same conditions as previously described 25 except that the annealing temperature for PCR of PL611 was 46 °C, 40 cycles were used and the PCR products were purified by passing the reaction through an ultrafiltration membrane (Qiagen).
Recombineering reaction. Bacterial artificial chromosome (BAC) clones from the indexed mouse C57BL/6J libraries RPCI23 or RPCI24 were selected using the htgt software. Four different BAC clones were selected for each targeting vector construction. High-throughput targeting vectors production was modified from the method described using the λ defective prophage containing plasmid pSim18 (ref. 25) . However, PCR fragments for recombineering were purified by using a 96-well ultrafiltration membrane (Qiagen) by washing three times with and then resuspending in high-performance liquid chromatography grade water. The recombineering fragments were electroporated into bacteria in 96-well format using an ECM630 (BTX Harvard Apparatus).
Kanamycin/neomycin selective targeting vectors (Neo-TVs).
Vectors were created entirely in liquid phase. Initially the HPmK3 cassette was PCR amplified with 20 bp or 21 bp primers appended respectively to 50-bp gene-specific recombineering oligonucleotides (designated as U and D). The HPmK3 cassette appended PCR product was recombineered into the BAC clone thus deleting the miRNA target. The targeting vector insert was retrieved by recombineering into the PL611 vector backbone PCR amplified with 22 bp and 20 bp primers appended to 50-bp gene-specific recombineering oligonucleotides (designated as G5 and G3). After miniprep and transformation into chemically competent E. coli DH10B the Neo-TVs were digested by restriction enzymes and sequenced and those that passed quality control were archived as frozen bacterial glycerol stocks.
PuroDtk selective targeting vectors (Puro-TV).
Vectors were created by a third round of recombineering in which the PGK-EM7-Puro∆tk-bpA fragment
